ABCELLERA BIOLOGICS INC's ticker is ABCL and the CUSIP is 00288U106. A total of 125 filers reported holding ABCELLERA BIOLOGICS INC in Q4 2021. The put-call ratio across all filers is 0.67 and the average weighting 1.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,192,762 | -56.1% | 259,296 | -38.3% | 0.00% | -100.0% |
| Q2 2023 | $2,714,989 | +2.5% | 420,277 | +19.6% | 0.00% | 0.0% |
| Q1 2023 | $2,649,149 | -43.7% | 351,346 | -24.4% | 0.00% | 0.0% |
| Q4 2022 | $4,709,193 | +18.7% | 464,876 | +15.9% | 0.00% | 0.0% |
| Q3 2022 | $3,968,000 | +58.9% | 401,217 | +71.1% | 0.00% | 0.0% |
| Q2 2022 | $2,497,000 | +127.2% | 234,487 | +108.0% | 0.00% | – |
| Q1 2022 | $1,099,000 | -43.3% | 112,725 | -16.8% | 0.00% | – |
| Q4 2021 | $1,937,000 | +415.2% | 135,449 | +622.6% | 0.00% | – |
| Q3 2021 | $376,000 | -44.9% | 18,745 | -39.6% | 0.00% | – |
| Q2 2021 | $683,000 | -27.5% | 31,055 | +12.0% | 0.00% | – |
| Q1 2021 | $942,000 | – | 27,732 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Founders Fund VII Management, LLC | 3,773,530 | $75,584,000 | 86.10% |
| Gruss & Co., LLC | 430,407 | $8,625,000 | 24.12% |
| SB Management Ltd | 9,817,190 | $196,736,000 | 20.16% |
| GUARDIAN CAPITAL ADVISORS LP | 3,836,414 | $76,767,000 | 7.97% |
| Intellectus Partners, LLC | 1,223,429 | $24,518,000 | 5.93% |
| HARVARD MANAGEMENT CO INC | 4,105,095 | $82,266,000 | 4.82% |
| ArchPoint Investors | 461,289 | $9,244,000 | 2.77% |
| Belmont Capital, LLC | 150,000 | $3,006,000 | 2.44% |
| CLOUGH CAPITAL PARTNERS L P | 971,297 | $19,465,000 | 1.18% |
| Orbimed Advisors | 4,180,768 | $83,783,000 | 0.92% |